Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine.
Workman
Paul
P
de Bono
Johann
J
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D016374:Oncogene Proteins v-abl / Q000187:drug effects; D009857:Oncogenes; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects
D000970:Antineoplastic Agents; D016374:Oncogene Proteins v-abl; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human